REFERENCES
- Klote MM, Agodoa LY, Abbott KC. Risk factors for Mycobacterium tuberculosis in U.S. chronic dialysis patients. Nephrol Dial Transplant. 2006; 21: 3287–3292
- Ahmed AT, Karter AJ. Tuberculosis in California dialysis patients. Int J Tuberc Lung Dis. 2004; 8: 341–345
- Ahmed W, Rylance PB, Jackson MA, Nicholas JC, Odum J. A diabetic haemodialysis patient with dysphagia and weight loss. Nephrol Dial Transplant. 2003; 18: 1018–1020
- Fujiwara Y, Osugi H, Takada N, Takemura M, Lee S, Ueno M, Fukuhara K, Tanaka Y, Nishizawa S, Kinoshita H. Esophageal tuberculosis presenting with an appearance similar to that of carcinoma of the esophagus. J Gastroenterol. 2003; 38: 477–481
- Mazurek GH, Jereb J, LoBue P, Iademarco MF, Metchock B, Vernon A. Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Morb Mortal Wkly Rep. 2005; 54: 49–55
- Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J. 2007; 30: 945–950
- Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med. 2008; 149: 177–184
- Poduval RD, Hammes MD. Tuberculosis screening in dialysis patients—is the tuberculin test effective?. Clin Nephrol. 2003; 59: 436–440